您的购物车当前为空
别名 多沙普仑, Dopram
Doxapram (Dopram) 是一种呼吸兴奋剂,抑制 TASK-1,TASK-3 和 TASK-1/TASK-3 异二聚体通道,可用于研究早产儿呼吸暂停和慢性阻塞性肺疾病恶化引起的通气衰竭。

Doxapram (Dopram) 是一种呼吸兴奋剂,抑制 TASK-1,TASK-3 和 TASK-1/TASK-3 异二聚体通道,可用于研究早产儿呼吸暂停和慢性阻塞性肺疾病恶化引起的通气衰竭。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 2 mg | ¥ 108 | In Stock | |
| 5 mg | ¥ 148 | In Stock | |
| 10 mg | ¥ 198 | In Stock | |
| 25 mg | ¥ 372 | In Stock |
Doxapram 相关产品
| 产品描述 | Doxapram (Dopram) is a respiratory stimulant that inhibits TASK-1, TASK-3, and TASK-1/TASK-3 heterodimer channels and is used to study ventilatory failure caused by apnea of prematurity and exacerbation of chronic obstructive pulmonary disease. |
| 靶点活性 | K+ currents recorded (type I cells):13 mM, TASK1:410 nM (EC50), TASK3:37 μM (EC50), TASK1/TASK3:9 μM (EC50) |
| 体外活性 | Doxapram 可抑制TASK-1(EC50=410 nM)、TASK-3(EC50=37 μM)、TASK-1/TASK-3(EC50=9 μM)异二聚体通道功能。Doxapram 还以浓度依赖性方式诱发 3H 溢出,Doxapram 诱发的释放受到 Ca2+ 通道阻断剂硝苯地平(5 mM)的抑制。[1] |
| 别名 | 多沙普仑, Dopram |
| 分子量 | 378.51 |
| 分子式 | C24H30N2O2 |
| CAS No. | 309-29-5 |
| Smiles | O=C1N(CC)CC(CCN2CCOCC2)C1(C=3C=CC=CC3)C=4C=CC=CC4 |
| 密度 | 1.31g/cm3 |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | Ethanol: 50 mg/mL, (132.10 mM.), Sonication is recommended. DMSO: 50 mg/mL (132.1 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (5.28 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容